Hopeful new MS treatment

A small, exploratory/feasibility trial in just ten patients has shown that a new therapy for MS that teaches the immune system to recognise and ignore its own nerve tissue, appears to be safe and well tolerated in humans.
 
The new treatment works by creating tolerance to selective myelin proteins that are attacked by the immune system (in MS) when it fails to recognise them as a normal part of the body.
 
If larger studies show that this therapy is able to slow down or stop the disease, this would be a completely new way to treat autoimmune diseases such as multiple sclerosis (MS) and type 1 diabetes.

For more details and a link to the original article, read the coverage from the US National MS Society here.